The United States' generic drug market continues to play a crucial role in reducing healthcare costs while ensuring access to high-quality medications. As of 2024, the market was valued at USD 163.68 billion and is anticipated to grow at a CAGR of 12.00%, reaching nearly USD 508.37 billion by 2034. For a detailed breakdown of trends, projections, and key players, check out the Expert Market...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Русский
Română
Português
Ελληνικά
Tiếng Việt